RENAL PELVIS CANCER
Clinical trials for RENAL PELVIS CANCER explained in plain language.
Never miss a new study
Get alerted when new RENAL PELVIS CANCER trials appear
Sign up with your email to follow new studies for RENAL PELVIS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Smart Bomb' drug seeks to target multiple advanced cancers
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of a new investigational drug called LY4052031 for people with advanced or metastatic solid tumors. The drug is designed to target a specific protein found on many cancer cells, delivering its medicine dire…
Matched conditions: RENAL PELVIS CANCER
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New cancer drug enters human testing for multiple advanced tumors
Disease control Recruiting nowThis is the first human study of an experimental cancer drug called LY4101174. Researchers want to find a safe dose and see if it can help control advanced cancers that have spread or returned after other treatments. The study will enroll about 490 people with various solid tumor…
Matched conditions: RENAL PELVIS CANCER
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC